Aurobindo Pharma on Tuesday said it has received the nod from the United States health regulator to manufacture and market its Valacyclovir Hydrochloride tablets, used for the treatment of chicken pox.
The company has received U.S. Food and Drug Administration (FDA) approval to market Valacyclovir Hydrochloride tablets, used to treat cold sores, genital herpes and chicken pox, Aurobindo Pharma said in a filing to the Bombay Stock Exchange.
The tablets will be available in strengths of 500 mg (base) and 1 g (base), the filing added.
Aurobindo now has a total of 117 abbreviated new drug approvals (ANDA) from the U.S. Food and Drug Administration (FDA), it said.
